Academic Journal
Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-analysis.
| العنوان: | Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-analysis. |
|---|---|
| المؤلفون: | Gubatan, John, Barber, Grant E., Nielsen, Ole Haagen, Juhl, Carsten Bogh, Maxwell, Cynthia, Eisenberg, Michael L., Streett, Sarah E. |
| المصدر: | Clinical Gastroenterology & Hepatology; Aug2023, Vol. 21 Issue 9, p2222-2238, 17p |
| مستخلص: | Studies evaluating reproductive outcomes among male patients with inflammatory bowel disease (IBD) are limited. We evaluated use of IBD medications and association with semen parameters, a proxy of male fertility, and adverse pregnancy outcomes (early pregnancy loss [EPL], preterm birth [PB], congenital malformations [CM]). We searched Medline, Embase, Scopus, and Web of Science (PROSPERO CRD42020197098) from inception to April 2022 for studies reporting semen parameters and adverse pregnancy outcomes among male patients exposed to biologics, thiopurine, or methotrexate. Standardized mean difference, prevalence, and odds ratios (ORs) of outcomes were pooled and analyzed using a random effects model. Ten studies reporting semen parameters (268 patients with IBD) and 16 studies reporting adverse pregnancy outcomes (over 25,000 patients with IBD) were included. Biologic, thiopurine, or methotrexate use were not associated with decreased sperm count, motility, or abnormal morphology compared with nonexposed patients. The prevalence of adverse pregnancy outcomes with paternal biologic (5%), thiopurine (6%), or methotrexate (6%) exposure was comparable to nonexposed patients (5%). Biologic use was not associated with risk of EPL (OR, 1.26; I2 = 0%; P =.12), PB (OR, 1.10; I2 = 0%; P =.17), or CM (OR, 1.03; I2 = 0%; P =.69). Thiopurine use was not associated with risk of EPL (OR, 1.31; I2 = 19%; P =.17), PB (OR, 1.05; I2 = 0%; P =.20), or CM (OR, 1.07; I2 = 7%; P =.34). Methotrexate use was not associated with risk of PB (OR, 1.06; I2 = 0%; P =.62) or CM (OR, 1.03; I2 = 0%; P =.81). Biologic, thiopurine, or methotrexate use among male patients with IBD are not associated with impairments in fertility or with increased odds of adverse pregnancy outcomes. [Display omitted] [ABSTRACT FROM AUTHOR] |
| Copyright of Clinical Gastroenterology & Hepatology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder كن أول من يترك تعليقا!